<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"T-cadherin":1,
"locally advanced breast cancer":1,
"neoadjuvant chemotherapy":1,
"Câncer de tireoide":1,
"Hashimoto's thyroiditis":1,
"Microcarcinoma":2,
"Thyroid cancer":34,
"Tireoidite de Hashimoto":1,
"cohort study":1,
"ionizing radiation":1,
"occupational exposure":2,
"radiologic technologists":1,
"AICAR":1,
"CXCL8":1,
"Chemokines":1,
"Migration":1,
"Breast microcalcification":1,
"Core needle biopsy":3,
"Meta-analysis":4,
"Vacuum-assisted biopsy":1,
"Latero-cervical lymph node metastases":1,
"Papillary thyroid cancer":11,
"Thyroid cancer metastases":1,
"Thyroid cancer outcome":1,
"Thyroid cancer-related mortality":1,
"99mTc-MIBI scintigraphy":1,
"BRAFV600E":1,
"Bio-chemical incomplete response":1,
"Metastatic thyroid cancer":1,
"Lymph node dissection":1,
"Metastasis":5,
"Papillary thyroid carcinoma (PTC)":2,
"Right paraesophageal lymph node":1,
"Carcinoma arising from thyroglossal duct cyst":1,
"Cystic squamous cell carcinoma":1,
"HPV-related squamous cell carcinoma":1,
"Thyroglossal duct cyst":1,
"p16 immunohistochemistry":1,
"Shear wave":1,
"cancer":6,
"elastography":1,
"thyroid nodules":5,
"ultrasound":4,
"diagnostic efficacy":1,
"head and neck":2,
"invasive techniques":1,
"thyroid/parathyroid":2,
"computer-assisted":1,
"diagnosis":4,
"informatics/image processing":1,
"lymph nodes":3,
"pattern recognition":1,
"thyroid carcinoma":4,
"Breast carcinoma metastatic":1,
"GATA3":1,
"cytology":2,
"fine needle aspiration":2,
"immunohistochemistry":3,
"carcinoma, thyroid":1,
"positive margin":1,
"radioactive iodine":2,
"thyroid neoplasm":1,
"BRAF":2,
"EZH1":1,
"Molecular diagnostics":1,
"RAS genes":1,
"TERT":2,
"Thyroid nodule":7,
"endoscopic":1,
"submental":1,
"thyroidectomy":3,
"transoral":1,
"Lung cancer":3,
"spectral CT imaging":1,
"tomography":1,
"Lactotrope":1,
"Menin":1,
"Pituitary":1,
"Prolactinoma":1,
"Ral":1,
"Ras":1,
"Calcitonin":1,
"Primary medullary thyroid carcinoma":1,
"Tumour staging":1,
"[18F]DOPA PET/CT":1,
"ultrasonography":8,
"Biopsy, fine-needle":1,
"Biopsy, large-core needle":1,
"Thyroid neoplasms":4,
"bone growth":1,
"hypothyroidism":2,
"puberty":1,
"Clinical practice":1,
"Mutation":2,
"acute pancreatitis":1,
"autoimmune thyroiditis":1,
"gonadotropin-releasing hormone agonist":1,
"myxedema coma":1,
"TNRC6C-AS1":1,
"UNC5B":1,
"miR-129-5p":1,
"FTIR":1,
"Follicular thyroid carcinoma (FTC)":1,
"PCA":1,
"MCF-7 cell":1,
"Notch signaling pathway":1,
"T47D cell":1,
"breast cancer":5,
"radiosensitivity":1,
"MEN1":1,
"Multiple endocrine neoplasia type 1":1,
"Parathyroid carcinoma":2,
"Primary hyperparathyroidism":2,
"Surgery":2,
"Extrathyroidal extension":2,
"Primary tumor size":1,
"Recurrence":5,
"Biomarker":2,
"Hepatocellular carcinoma":4,
"SSR3":1,
"Survival analysis":3,
"GLI1":1,
"GLI2":1,
"SHH":1,
"SOX2":1,
"Hook1":1,
"Immunochemistry":2,
"Prognosis":10,
"SHP2":1,
"Biphenotypic":1,
"Collision tumor":1,
"Composite tumor":1,
"Next-generation sequencing":1,
"Tumor-to-tumor metastasis":1,
"Gamma-probe technique":1,
"Lymphoscintigraphy":1,
"Sentinel lymph node biopsy":1,
"Vital blue dye technique":1,
"differentially expressed genes":2,
"differentially expressed long non-coding RNAs":1,
"papillary thyroid carcinoma":17,
"progression":1,
"18F-FDG PET/CT":1,
"incidental":1,
"PINX1":1,
"Prognostic marker":1,
"Esophageal squamous cell carcinoma":1,
"Lymphocyte-to-monocyte ratio":1,
"Chromophobe renal cell carcinoma":1,
"Xanthogranulomatous pyelonephritis":1,
"Epidemiology":1,
"Incidence":2,
"Mortality":1,
"Sex differences":2,
"Trends":1,
"Graves' disease":1,
"Electrophoresis":1,
"mass spectrometry":1,
"proteomics":3,
"serum":2,
"bioinformatical analysis":1,
"hub genes":1,
"methylation":1,
"pathways":1,
"thyroid cancer (THCA)":1,
"IGF-1 receptor":1,
"folliculogenesis":1,
"hyperplasia":1,
"insulin receptor":1,
"thyroid":7,
"Microwave":1,
"Euthyroid nodular goiter":1,
"Insulin resistance":1,
"Pulse wave velocity":1,
"Strain index":1,
"Pregnancy":1,
"Subtype":1,
"Differentiated thyroid carcinoma":6,
"Hemianopsia":1,
"Pituitary adenomas":1,
"Thyroid-stimulating hormone":1,
"BRAF(V600E) mutation":1,
"CK19":2,
"Central cervical lymph node metastases":1,
"Galectin-3":1,
"Human bone marrow endothelial cell-1":1,
"Thyroid peroxidase":1,
"propensity score matching":1,
"telomerase":1,
"telomerase reverse transcriptase (TERT) promoter mutation":1,
"transcriptome":2,
"Iodine":1,
"Perchlorate":1,
"Thiocyanate":1,
"Urine":1,
"BRAFV600E mutation":1,
"apoptosis":3,
"epithelial mesenchymal transition":1,
"microRNA-150-5p":1,
"proliferation":2,
"anlotinib":1,
"clinical trial":1,
"medullary thyroid carcinoma":3,
"Central compartment":1,
"Level VI":1,
"Lymph node metastases":1,
"Neck dissection":2,
"Radiation dosimetry":1,
"Radiation risk":1,
"Radioiodine":1,
"Therapeutic NM":1,
"Lobectomy":1,
"Papillary thyroid microcarcinoma":2,
"Systematic review":1,
"Total thyroidectomy":1,
"Akt-mTOR pathway":1,
"Malignancy":2,
"PDPK1":1,
"miR-718":1,
"Chemosensitivity":1,
"Dauricine":1,
"Glycolysis":1,
"MiR-199a":1,
"Ki-67":1,
"Lipocalin-2 (Lcn2)":1,
"NFκB":1,
"Pediatric thyroid cancer":1,
"Glycol chitosan":1,
"doxorubicin⋅hydrochloride":1,
"local drug delivery system":1,
"visible light irradiation":1,
"Cancer registries":1,
"Cancer survival":1,
"Excess mortality":1,
"Inequalities":1,
"STAT3":1,
"Schisandrin B":1,
"Triple negative breast cancer":1,
"Clinicopathological characteristic":1,
"Northwest China":1,
"retrospective study":1,
"oncocytic variant papillary thyroid carcinoma":1,
"circulating epithelial cells":1,
"epithelial cell adhesion molecule":1,
"podoplanin":1,
"benign thyroid nodule":1,
"initial ablation ratio":1,
"radiofrequency ablation":1,
"therapeutic success":1,
"thermal ablation":1,
"computed tomography":1,
"persistent":1,
"follicular variant of papillary thyroid carcinoma":1,
"gene expression profiling":1,
"massively parallel sequencing":1,
"molecular profile":1,
"children":1,
"lenvatinib":4,
"radioiodine-refractory thyroid carcinoma":1,
"refractory":1,
"Approach":1,
"Guidelines":1,
"Oncology":1,
"Survey":1,
"Anaplastic thyroid cancer":2,
"Natural killer cell":1,
"PD-1":1,
"Tim-3":1,
"Circulating tumour DNA":1,
"Personalised medicine":1,
"Complex structure":1,
"Growth inhibition":1,
"IL-1RAcP":1,
"Triple-negative breast cancer":1,
"scFv 12H7":1,
"Combination effect":1,
"Nanoparticles":1,
"Selenium":1,
"X-ray":1,
"ORPH":1,
"PKM2":2,
"Tumor growth":1,
"miR-491-5p":1,
"radioiodine refractoriness":1,
"risk factors":2,
"scoring system":1,
"Hashimoto's encephalopathy":1,
"MRI":1,
"Parkinsonism":1,
"Pathology":2,
"SREAT":1,
"Tumor-like lesions":1,
"GPER1":1,
"Shenmai injection":1,
"Treg cells":1,
"miR-103":1,
"Cribado":1,
"Cáncer de mama":1,
"Cáncer de próstata":1,
"Cáncer de tiroides":1,
"Incidentaloma":1,
"Incidentalomas":1,
"Overdiagnosis":1,
"Prostate cancer":1,
"Screening":2,
"Sobrediagnóstico":1,
"BRAFv600e test":1,
"FNA-Tg":1,
"FNAC":1,
"Lymph node metastasis":2,
"C-reactive protein":1,
"Recurrence-free survival":1,
"branchial cleft cyst":1,
"ectopic thyroid":1,
"neck":1,
"thyroid pathology":1,
"Hürthle cell carcinoma (HCC)":1,
"close homolog of L1 (CHL1)":1,
"prognostic biomarker":1,
"whole-transcriptome sequencing":1,
"fine-needle aspiration":3,
"thyroid imaging reporting and data system":1,
"EGFR":1,
"LRIG1":1,
"Non-small cell lung cancer":2,
"TTF-1/Nkx2 1":1,
"β-catenin":1,
"fine-needle biopsy":1,
"needle biopsy clinic":1,
"review":1,
"technique":1,
"thyroid nodule/diagnostic imaging":1,
"Antagonistes de la vitamine K":1,
"Cancer du poumon non à petites cellules":1,
"Hyperthyroidism":1,
"Hémorragie":1,
"Immune related adverse event":1,
"Immunotherapy":1,
"Immunothérapie":1,
"Vitamin K antagonists":1,
"Évènement indésirable grave":1,
"The Cancer Genome Atlas":3,
"competing endogenous RNAs network":1,
"long noncoding RNAs":1,
"Contralateral central lymph node metastasis":1,
"TSG101":1,
"anoikis resistance":1,
"complication":1,
"cosmetic":1,
"endoscopic thyroidectomy with central neck dissection":1,
"transoral vestibular approach":1,
"LATS1":1,
"LINC01186":1,
"YAP1":1,
"long noncoding RNA":1,
"bioinformatics analysis":1,
"collagen":2,
"extracellular matrix":1,
"signaling pathways":1,
"inherited cancer susceptibility":1,
"multiple primary malignant tumors":1,
"mutation profiling":1,
"next generation sequencing":1,
"synchronous carcinoma":1,
"CD56":1,
"Gal-3":1,
"HBME-1":1,
"NIFTP":3,
"follicular variant":1,
"papillary carcinoma":1,
"EWSR1 gene":1,
"NR4A3 gene":1,
"extraskeletal myxoid chondrosarcoma":1,
"fluorescence in situ hybridization":1,
"Afirma":1,
"Rosetta Reveal":1,
"gene expression classifier":1,
"indeterminate thyroid cytology":1,
"miRNA classifier in":1,
"endoscopic ultrasound":1,
"liquid-based cytology":2,
"pancreatic metastasis":1,
"small-cell carcinoma":1,
"Differentiated thyroid cancer":3,
"Molecular-targeting therapy":1,
"Multikinase inhibitor":1,
"Radioactive iodine refractory":1,
"EMT":1,
"IRF-1":1,
"Metformin":1,
"Verteporfin":1,
"YAP":1,
"microRNA (miRNA)":1,
"risk score":1,
"Anti-thyroglobulin":1,
"Cystathione β-synthase":1,
"NAMPT":1,
"follicular adenoma":1,
"follicular carcinoma":1,
"AKT":1,
"chemotherapeutic agent":1,
"evodiamine":1,
"synergism":1,
"Renal transplantation":1,
"South Korea":1,
"dose threshold":1,
"dose-volume parameters":1,
"intensity-modulated radiotherapy":1,
"nasopharyngeal carcinoma":1,
"Artery-first approach":1,
"Borderline resectable pancreatic cancer":1,
"Conventional approach":1,
"Mesenteric approach":1,
"Pancreatic ductal adenocarcinoma":1,
"Pancreaticoduodenectomy":1,
"R0 resection":1,
"Resectable pancreatic cancer":1,
"Superior mesenteric artery":1,
"Papillary":1,
"TNM staging":1,
"Adrenal tumors":1,
"Adrenalectomy":1,
"Adrenocortical carcinoma (ACC)":1,
"Case report":2,
"Hormone secretion":1,
"Nonfunctioning":1,
"Gene":1,
"Tumor stage":1,
"miRNA":1,
"Epithelial-mesenchymal transition":1,
"Fibroblast activation protein alpha":1,
"Gastric cancer":2,
"Peritoneal metastasis":1,
"Genetic feature":1,
"Melanin":1,
"CTNNBIP1":1,
"Circular RNA":1,
"Wnt/β-catenin":1,
"circRNA_102171":1,
"CCND1":1,
"CCND1b":1,
"cyclin D1":1,
"cyclin D1b":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"polymorphism":1,
"131I radiotherapy":1,
"SNPs":1,
"toxicity reactions":1,
"Hormone replacement therapy":1,
"Hypothalamic hypopituitarism":1,
"Pan-hypopituitarism":1,
"Recessus infundibuli":1,
"Small cell lung cancer":1,
"Suprasellar":1,
"Burkitt’s lymphoma":1,
"Thyroid lymphomas":1,
"Iran":1,
"Population-based":1,
"Registry":1,
"Fine-needle aspiration biopsy":1,
"RNA":2,
"RNA integrity number":1,
"Carcinoma":2,
"DNA methylation":1,
"Papillary thyroid":1,
"miR-146b":1,
"miR-21":1,
"microRNA":1,
"hypercalcemia":1,
"sorafenib":1,
"Drugs":1,
"Metabolic":1,
"Overall survival":2,
"MET":1,
"PI3K/AKT":1,
"XIST":1,
"miR-34a":1,
"INPPL1 expression":1,
"Chemistry":1,
"Genetics":1,
"Molecular Genetics":1,
"Cardiac function":1,
"Myocardial perfusion":1,
"Suppression time":1,
"Thyroid stimulating hormone":1,
"Fluorescence imaging":1,
"γ-glutamyl hydroxymethyl rhodamine green":1,
"γ-glutamyltranspeptidase":1,
"Ablation techniques":1,
"NADP":1,
"Succinate dehydrogenase":1,
"Breast cancer stem cells":1,
"E2F1":1,
"LINC00511":1,
"Nanog":1,
"miR-185-3p":1,
"Cowden’s syndrome":1,
"Mucocutaneous manifestations":1,
"PTEN hamartoma tumor syndrome":1,
"Metabolomics":1,
"Multinodular goiter":1,
"NMR":1,
"Breast neoplasms":1,
"Lentivirus":1,
"Neoplasm metastasis":1,
"Rhomboid domain - containing 1":1,
"Small interfering":1,
"diabetes mellitus":1,
"gestational diabetes mellitus":1,
"Lymphatic metastasis":1,
"FokI polymorphism":1,
"VDR gene":1,
"Clinicopathological predictors":1,
"Disease-free survival":1,
"Sorting nexin 10":1,
"Stomach adenocarcinoma":1,
"Weighted gene co-expression network analysis":1,
"Endocrine":1,
"Oncology: Endocrine":1,
"Pediatrics":1,
"pediatric differentiated thyroid carcinoma":1,
"radioiodine treatment":1,
"salivary gland dysfunction":1,
"xerostomia":1,
"Basal cell carcinoma":1,
"Chronic lymphocytic leukemia":1,
"Renal cell carcinoma":1,
"Second primary cancer":1,
"IR-A/IGF2 autocrine loop":1,
"hybrids receptors":1,
"insulin receptor isoforms":1,
"insulin/IGF system":1,
"thyroid cancer stem cells":1,
"localized drug delivery":1,
"matrix metalloproteinase":1,
"tumor extracellular matrix":1,
"tumor penetration":1,
"Proteinuria":1,
"Radioactive iodine- refractory differentiated thyroid cancer":1,
"Thrombotic microangiopathy":1,
"Hürthle cell adenoma":1,
"papillary cell carcinoma":1,
"Chemotherapy":1,
"Locoregional recurrence":1,
"Lymph nodes metastasis":1,
"Treatment strategy":1,
"Trichilemmal carcinoma":1,
"BRAF inhibition":1,
"Cancer therapy":1,
"MEK inhibition":1,
"Multikinase inhibitors":1,
"Selective kinase inhibitors":1,
"Targeted drugs":1,
"Tracheal invasion":1,
"Well-differentiated thyroid carcinoma (DTC)":1,
"ear, nose and throat/otolaryngology":1,
"head and neck cancer":1,
"head and neck surgery":1,
"otolaryngology / ENT":1,
"surgical oncology":1,
"Cabozantinib":1,
"Chronic kidney failure":1,
"Medullary thyroid cancer":1,
"Renal adverse events":1,
"Tyrosine kinase inhibitor":1,
"Disease recurrence":1,
"Poorly differentiated thyroid carcinoma":1,
"Survival rate":1,
"Thyroglobulin level":1,
"medical expertise of interdependence of diseases bring to disability and death with the effect of the consequences of the Chornobyl accident":1,
"radiation exposure":1,
"victims of the accident at the Chornobyl Nuclear Power Plant":1,
"Dynamic risk stratification":1,
"Inflammation":1,
"Neutrophil-to-lymphocyte ratio":1,
"CLDN10":1,
"PTC":1,
"tumorigenesis":1,
"Parathyroid cyst":1,
"genistein":1,
"invasion":2,
"HGF":1,
"S100A11":1,
"DTC":1,
"brain metastases":1,
"prevalence":1,
"therapies":1,
"RET proto-oncogene":1,
"Benign pathologies":1,
"TENIS syndrome":1,
"metastatic sites":1,
"radio iodine":1,
"whole body 131I scan":1,
"Atypia of undetermined significance”/”follicular lesion of uncertain significance":1,
"BRAF mutations":1,
"Anaplastic":1,
"Cancer disparities":1,
"Clinical trial enrollment":1,
"Endocrine cancer":1,
"Health disparities":1,
"Parity":1,
"Prognostic factors":1,
"South Africa":1,
"Survival":1,
"iodine negative":1,
"liver surgery":1,
"MCM3":1,
"MCM7":1,
"Salivary adenoid cystic carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年11月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
